Publication planning is one of the most important components of a communications strategy for a drug or device, and it forms the base upon which pharma companies can share key scientific data on a product and spread awareness. A requirement in many countries, publishing critical data from clinical trials informs key external stakeholders of a [...]

At Six Degrees Medical (SDM), we take the work we do very seriously. As experts in medical communications, we understand that our contributions help our clients to deliver life-changing pharmaceutical treatments into the hands of the patients who need them most. We’re driven by a purpose bigger than simply punching the clock in a 9 [...]

The word “eLearning” has come so far since it was first coined in 1999.[1] Twenty years later, eLearning reaches far beyond the confines of the simple lowercase “e” for electronic. It is highly adaptable, often social and usually competitive. Continuing technological advances in virtual reality, augmented reality, artificial intelligence, and more are transforming the learning [...]

Trends to watch in 2019 include an increasing emphasis on highly targeted drugs; new healthcare applications for artificial intelligence (AI) and machine learning (ML); eMeeting innovations; and pressure to reduce drug prices while improving patient outcomes. The following is a round-up of what we’re expecting to see this year: Outcome-Based Care Payers, healthcare professionals and [...]

Major news from 2018 was the FDA’s announcement of upcoming changes to  the processes of the drug review office. Included in the modernization, per a written statement[1] from the FDA Commissioner Scott Gottlieb, is to provide FDA scientists and medical officers the opportunity to become “thought leaders”[2] in their fields. The proposals for change include [...]

Having worked with pharmaceutical clients for more than a decade, the team at Six Degrees Medical understands the incredible pace of change inherent in the industry. Ongoing changes to regulations, new research and revolutionary new treatment methods require organizations like the ISPE to prioritize innovation. With this in mind, the ISPE has launched a philanthropic [...]

As the UK prepares to exit the European Union, regulatory responsibilities for medication manufacturers are shifting. Companies potentially affected by Brexit need to ensure that their marketing authorisation remains valid in the coming months. A recent survey[1] conducted by the European Medicines Agency (EMA) showed that 58% of marketing authorisation holders with regulatory ties in [...]

You are busy. Your stakeholders are busy. Your target audience is busy. While nothing will ever replace the value of a face-to-face meeting, the pace of life today demands a more convenient and cost-effective solution. Sure, there are plenty of virtual meeting platforms available, but until now, no platform has been able to meet the [...]

The Drug Information Association (DIA) provides a global stage for the discussion of healthcare challenges, within a collaborative and neutral setting. For more than 50 years, stakeholders from around the world have gathered to openly share knowledge and generate new insights. The annual DIA Global Annual Meeting is the largest, longest-running event in the life [...]